Skip to main content
. 2018 Jul 13;7(5):243–250. doi: 10.1159/000490383

Fig. 3.

Fig. 3

Mean ThyPRO composite score of QoL of the study population at baseline (a) and at the 12-month follow-up (b) in comparison with available reference scores for the general population (a, b) [14] as well as newly diagnosed hypothyroid patients in the untreated state (a) [4] and 6 months after the initiation of monotherapy with L-T4 (b) [4].